RenovionOct 10, 20231 minLung TransplantInterview with the Lung Transplant Foundation: Participating in a Lung Transplant Clinical TrialCarolyn Durham, CSO at Renovion and Amy S., ED at the LTx Foundation discuss real-world experience of being in a clinical trial in LTx.
RenovionApr 18, 20232 minLung TransplantFirst Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung TransplantSource | Business Wire April 18, 2023 08:52 AM Eastern Daylight Time CHAPEL HILL, N.C - Renovion, Inc. today announced that the first...
RenovionMar 30, 20232 minLung TransplantRenovion Receives FDA Fast Track Designation for ARINA-1 for the Prevention of BOS Progression in LTThe Fast Track designation accelerates the FDA regulatory path for ARINA-1 for the prevention of bronchiolitis obliterans syndrome (BOS)...
RenovionAug 2, 20222 minLung TransplantRenovion Receives Notice of Study May Proceed Status for Lung Transplant ProgramRenovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for serious chronic inflammatory lung diseases...